LEPABE, Departamento de Engenharia Química, Faculdade de Engenharia da Universidade do Porto, Rua Dr. Roberto Frias, 4200-465 Porto, Portugal; ALiCE-Associate Laboratory in Chemical Engineering, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, 4200-465 Porto, Portugal.
LEPABE, Departamento de Engenharia Química, Faculdade de Engenharia da Universidade do Porto, Rua Dr. Roberto Frias, 4200-465 Porto, Portugal; ALiCE-Associate Laboratory in Chemical Engineering, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, 4200-465 Porto, Portugal.
Int J Biol Macromol. 2023 Jan 1;224:1217-1227. doi: 10.1016/j.ijbiomac.2022.10.207. Epub 2022 Oct 26.
Co-encapsulation of retinoic acid (RA), curcumin and/or resveratrol into microparticles composed by alginic acid sodium and the ethyl cellulose + polyethylene glycol (EC + PEG) blend was proposed for the protection and co-delivery of these bioactive compounds. The final aim is to take benefit of combined therapeutic potential related to these molecules and use loaded microparticles obtained by spray-drying to improve the treatment of acute promyelocytic leukemia (APL). Alginic acid sodium-based emulsions were characterized regarding rheological properties (i.e. viscosity), stability and droplet size distribution. Biopolymer- and synthetic polymer-based microparticles loaded with RA, RA + curcumin, RA + resveratrol and RA + curcumin + resveratrol were produced with a product yield between 10 and 35 %. The obtained microparticles exhibited a variable form, a morphology that varied between a slightly and high rough surface and a mean diameter that ranged from 2.97 ± 0.04 and 88 ± 3 μm. Encapsulation efficiency was significantly influenced by the encapsulating agent(s) used in the microparticles formulations. The bioactive compounds that were co-encapsulated showed a similar release profile.
将维甲酸 (RA)、姜黄素和/或白藜芦醇共同包封到由海藻酸钠和乙基纤维素+聚乙二醇 (EC+PEG) 共混物组成的微球中,以保护和共递送这些生物活性化合物。最终目的是利用与这些分子相关的联合治疗潜力,并使用喷雾干燥获得的载药微球来改善急性早幼粒细胞白血病 (APL) 的治疗效果。对基于海藻酸钠的乳液进行了流变性质(即粘度)、稳定性和液滴尺寸分布的表征。采用生物聚合物和合成聚合物制备了载有 RA、RA+姜黄素、RA+白藜芦醇和 RA+姜黄素+白藜芦醇的微球,产率在 10%至 35%之间。所得微球具有不同的形态,表面略微粗糙到高度粗糙,平均直径在 2.97±0.04 至 88±3μm 之间。包封效率受微球配方中所用包封剂的显著影响。共同包封的生物活性化合物表现出相似的释放曲线。